Susan G. Komen for the Cure® Announces 2011 Brinker Award
Winners for Scientific Distinction
Armando Giuliano,
MD, and Carlos Arteaga, MD, are being
honored as this year's winners of the Susan G. Komen for the Cure®
Brinker Awards for Scientific Distinction in basic science and
clinical research. The awards will be presented on December 7 at
the 34th Annual San Antonio Breast Cancer Symposium where both Dr.
Giuliano and Dr. Arteaga will deliver keynote lectures.

Dr. Giuliano
is Executive Vice Chair of Surgery for Surgical Oncology at
Cedars-Sinai Medical Center and Dr. Arteaga is Professor of
Medicine and Cancer Biology at Vanderbilt University in Nashville,
Tennessee. Their institutions will receive a $25,000 award to
further their activities in breast cancer research.
Dr. Giuliano is receiving
the Brinker Award for Scientific Distinction in Clinical Research
for work that has led to less invasive surgical treatments for
breast cancer, specifically the removal of fewer lymph nodes in
certain women with early-stage breast cancer.
Dr. Arteaga is receiving
the Brinker Award for Scientific Distinction in Basic Science for
his work explaining the role of several key proteins and growth
factor receptors in the pathogenesis of breast cancer. His
translational research helped provide the rationale for many of new
targeted therapies.
"The pioneering work of
these two scientists has had, and will continue to have, a
significant impact on the quality of treatment and quality of life
for breast cancer survivors," said Eric P. Winer,
MD, Komen's Chief Scientific Advisor and Chair of Komen's
Scientific Advisory Board. "We're moving ever closer to an
era of more personalized and less invasive treatments for this
disease, thanks in large part to the foundation that these two
scientists have built in translational science and clinical
practice."
Komen is the largest private funder of breast cancer research,
this year investing $66 million to new research and programs to
advance understanding, prevention and treatment of breast cancer.
The Brinker Awards for Scientific Distinction were established in
1992 to recognize the efforts of pioneers in clinical research and
basic science. ■